617 related articles for article (PubMed ID: 20478485)
1. Targets for current pharmacologic therapy in cholesterol gallstone disease.
Di Ciaula A; Wang DQ; Wang HH; Bonfrate L; Portincasa P
Gastroenterol Clin North Am; 2010 Jun; 39(2):245-64, viii-ix. PubMed ID: 20478485
[TBL] [Abstract][Full Text] [Related]
2. Medicinal treatments of cholesterol gallstones: old, current and new perspectives.
Portincasa P; Di Ciaula A; Wang HH; Moschetta A; Wang DQ
Curr Med Chem; 2009; 16(12):1531-42. PubMed ID: 19355905
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.
Wang HH; Portincasa P; de Bari O; Liu KJ; Garruti G; Neuschwander-Tetri BA; Wang DQ
Eur J Clin Invest; 2013 Apr; 43(4):413-26. PubMed ID: 23419155
[TBL] [Abstract][Full Text] [Related]
4. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
[TBL] [Abstract][Full Text] [Related]
5. Therapy of gallstone disease: What it was, what it is, what it will be.
Portincasa P; Ciaula AD; Bonfrate L; Wang DQ
World J Gastrointest Pharmacol Ther; 2012 Apr; 3(2):7-20. PubMed ID: 22577615
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic reflections in cholesterol homeostasis and gallstone disease: a review.
Di Ciaula A; Wang DQ; Garruti G; Wang HH; Grattagliano I; de Bari O; Portincasa P
Curr Med Chem; 2014; 21(12):1435-47. PubMed ID: 24059227
[TBL] [Abstract][Full Text] [Related]
7. Lipid lowering drugs and gallstones: a therapeutic option?
Lioudaki E; Ganotakis ES; Mikhailidis DP
Curr Pharm Des; 2011 Nov; 17(33):3622-31. PubMed ID: 22074432
[TBL] [Abstract][Full Text] [Related]
8. Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation.
Portincasa P; Wang DQ
Med Chem; 2017; 13(5):421-429. PubMed ID: 28185534
[TBL] [Abstract][Full Text] [Related]
9. Ezetimibe prevents cholesterol gallstone formation in mice.
Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
[TBL] [Abstract][Full Text] [Related]
10. [Ezetimibe with statins].
Jublanc C; Giral P; Turpin G
Presse Med; 2006 Mar; 35(3 Pt 2):487-94. PubMed ID: 16550148
[TBL] [Abstract][Full Text] [Related]
11. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
Bruckert E; Giral P; Tellier P
Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
[No Abstract] [Full Text] [Related]
12. Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease.
Cariati A; Piromalli E
Expert Opin Pharmacother; 2012 Jun; 13(9):1223-7. PubMed ID: 22607008
[TBL] [Abstract][Full Text] [Related]
13. Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.
Ahmed MH
World J Gastroenterol; 2010 Apr; 16(13):1555-7. PubMed ID: 20355232
[TBL] [Abstract][Full Text] [Related]
14. Ezetimibe and bile acid sequestrants: impact on lipoprotein metabolism and beyond.
Couture P; Lamarche B
Curr Opin Lipidol; 2013 Jun; 24(3):227-32. PubMed ID: 23571732
[TBL] [Abstract][Full Text] [Related]
15. Intestinal sterol transporters and cholesterol absorption inhibition.
Davis HR; Tershakovec AM; Tomassini JE; Musliner T
Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients.
Ahmed O; Littmann K; Gustafsson U; Pramfalk C; Öörni K; Larsson L; Minniti ME; Sahlin S; Camejo G; Parini P; Eriksson M
J Am Heart Assoc; 2018 Dec; 7(24):e009876. PubMed ID: 30561264
[TBL] [Abstract][Full Text] [Related]
17. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
18. Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
Descamps OS; De Sutter J; Guillaume M; Missault L
Atherosclerosis; 2011 Aug; 217(2):308-21. PubMed ID: 21762916
[TBL] [Abstract][Full Text] [Related]
19. Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.
Patel SB
Curr Cardiol Rep; 2004 Nov; 6(6):439-42. PubMed ID: 15485605
[TBL] [Abstract][Full Text] [Related]
20. Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.
Jakulj L; Vissers MN; Groen AK; Hutten BA; Lutjohann D; Veltri EP; Kastelein JJ
J Lipid Res; 2010 Apr; 51(4):755-62. PubMed ID: 19828909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
